Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with ...

Earendil Labs and Sanofi today announced that they have entered into a license agreement for two potential first-in-class ...

Earendil Labs, an expert in AI-driven research and development of next-generation biologics therapeutics, and Sanofi have ...

Along with Le Fur – who was CEO at Sanofi predecessor Sanofi-Aventis in 2007 and 2008 – eureKING's backers include Michael Kloss, former head of Panasonic Healthcare, who will serve as CEO of ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...

Robert is currently chief digital officer at the cruise line firm Viking Cruises and will join Sanofi on 15th June. His brief is to drive Sanofi’s digital, data and technology strategy ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

Mr Radie held leadership roles as President, CEO and Director of Topaz Pharmaceuticals, a specialty pharmaceutical company acquired by Sanofi Pasteur, and Transmolecular, Inc., a biotechnology company ...

Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and ...